RxDoctor Payments Data

Everly Dehoyos

Family · San Antonio, TXNPI 1235726084

Payments from drug & device makers

$7,874in general payments, 2019–2025

Across 304 payments — averaging $25.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$714
  • AstraZeneca$557
  • Astellas Pharma US Inc$550
  • Johnson & Johnson$462
  • Daiichi Sankyo Inc.$426
  • Novartis$353
  • plus $5K from 45 others

What the payments were for

  • Food & beverage$6,45382%
  • Education$1,42218%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,874 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Letrozole26$700
Tamoxifen Citrate15$386
Potassium Chloride13$189
Ondansetron OdtOndansetron17$171

Paid to pharmacies, not to this prescriber.

Other family in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →